This inventor holds 16 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Heat Biologics, Inc., Heat Biologies, Inc., Kopfkino IP, LLC. Active years: 2018-2024.
Location History:
- Durhama, NC (US) (2020)
- Durham, NC (US) (2018 - 2023)
Company Filing History:
14 out of 15 
1 out of 1 
1 out of 1 Years Active: 2018-2024
Title: The Innovative Contributions of George Fromm in Biotechnology
Introduction
George Fromm is a prominent inventor based in Durham, NC, with a remarkable portfolio of 16 patents to his name. His groundbreaking work primarily focuses on the development of chimeric proteins that have significant implications for treating various diseases, particularly in the fields of immunotherapy for cancer and autoimmunity. Fromm's innovations are paving the way for new therapeutic strategies that could transform medical treatments.
Latest Patents
Among his latest patents, Fromm has developed compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins. These innovative chimeric proteins are designed to mediate therapeutic effects, potentially revolutionizing how diseases are treated. The inventions provide numerous embodiments, highlighting the fusions of extracellular domains of transmembrane proteins that can either stimulate or inhibit specific biological responses. This pioneering work showcases Fromm's dedication to improving healthcare through innovative biotechnological solutions.
Career Highlights
Throughout his career, George Fromm has made significant contributions while working at notable companies such as Heat Biologics, Inc. and Heat Biologies, Inc. His experience in these organizations has allowed him to further refine his research and innovative methodologies. Fromm’s commitment to pushing the boundaries of current medical treatments is evident through his extensive patent portfolio.
Collaborations
In his journey as an inventor, Fromm has collaborated with esteemed professionals, including Taylor H Schreiber and Suresh De Silva. These partnerships have fostered a vibrant exchange of ideas and expertise, further enhancing the quality and impact of his innovations in biotechnology.
Conclusion
George Fromm is a notable figure in the field of biotechnology, whose contributions are shaping the future of treatment for complex diseases. His innovative patents and collaborations highlight the importance of continued research and development in the healthcare sector. As he continues to advance the science of chimeric proteins, the implications of his work are poised to make a lasting impact on medical therapies.